Bavarian Nordic ASBVNKF 82 Market Cap is $2,072.1 Mil as of Jun. 28, 2026. GuruFocus rates BVNKF with a GF Score™ of 82/100 and a GF Value™ of $25.72 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,429 Biotechnology companies, Bavarian Nordic AS ranks better than 88.87% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Bavarian Nordic AS's share price for the quarter that ended in Mar. 2026 was $29.71. Bavarian Nordic AS's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 77.1 Mil. Therefore, Bavarian Nordic AS's market cap for the quarter that ended in Mar. 2026 was $2,291.9 Mil.
Bavarian Nordic AS's quarterly market cap
declined
from Sep. 2025 ($2,841.2 Mil) to Dec. 2025 ($2,309.0 Mil) and
declined
from Dec. 2025 ($2,309.0 Mil) to Mar. 2026 ($2,291.9 Mil).
Bavarian Nordic AS's annual market cap
increased
from Dec. 2023 ($2,044.1 Mil) to Dec. 2024 ($2,067.2 Mil) and
increased
from Dec. 2024 ($2,067.2 Mil) to Dec. 2025 ($2,309.0 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Bavarian Nordic AS's Enterprise Value for Today is $1,744.9 Mil.
Bavarian Nordic AS (OTCPK:BVNKF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Bavarian Nordic AS Market Cap Related Terms
Bavarian Nordic AS Market Cap Historical Data
* Premium members only.
The historical data trend for Bavarian Nordic AS's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Bavarian Nordic AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bavarian Nordic AS Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's Market Cap distribution charts can be found below:
* The bar in red indicates where Bavarian Nordic AS's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Bavarian Nordic AS's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bavarian Nordic AS (BVNKF) has a Market Cap of $2,072.1 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bavarian Nordic AS and its competitors. According to the industry distribution chart, Bavarian Nordic AS ranks #159 out of 1429 companies in the Biotechnology industry, placing it in the top 11.1%.
Is Bavarian Nordic AS's Market Cap too high?
Bavarian Nordic AS's current Market Cap is $2,072.1 Mil. The Biotechnology industry median Market Cap is 112.70. Bavarian Nordic AS's value of $2,072.1 Mil is 1738.6% above this industry median. Based on the distribution chart, Bavarian Nordic AS ranks #159 out of 1429 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bavarian Nordic AS has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bavarian Nordic AS ranks #159 out of 1429 companies for Market Cap. This places Bavarian Nordic AS in the top 11% of its industry — outperforming the majority of peers. The industry median Market Cap is 112.70. Bavarian Nordic AS's value of $2,072.1 Mil is 1738.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 112.70, based on 1,429 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bavarian Nordic AS's current Market Cap of $2,072.1 Mil is 1738.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Bavarian Nordic AS and its competitors. For the Biotechnology industry, the median Market Cap is 112.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bavarian Nordic AS's current Market Cap is $2,072.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (BVNKF) is currently considered Fairly Valued. The stock's GF Value™ is $25.72, compared to a current price of $27.80 — trading 8.1% above its estimated fair value. The current Market Cap is $2,072.1 Mil and 1738.6% above the Biotechnology industry median of 112.70. Bavarian Nordic AS's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Bavarian Nordic AS (BVNKF), the current Market Cap is $2,072.1 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bavarian Nordic AS (BVNKF) Overvalued in 2026?
Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued.
The current stock price of $27.80 is trading 8.1% above its estimated GF Value™ of $25.72.
GuruFocus considers Bavarian Nordic AS to be Fairly Valued.
Key valuation signals for BVNKF:
Market Cap: $2,072.1 Mil
GF Value™: $25.72 vs. price of $27.80 (8.1% above fair value)
Industry Position: 1738.6% above the Biotechnology median (#159 of 1429)
No single metric tells the full story. See the BVNKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
82GF Score
Get the complete analysis for BVNKF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BVNKF has been successfully added to your 
